I just started reading the Expansion Rule and am finding myself both confused and alarmed. At first blush, it all sounds good, but the ramifications are a bit, well, staggering.
First of all, I look at the justification for the expansion, which looks OK in part. The bits about having oversight over the testing labs looks good, as does the fact that ONC will have a more direct role in addressing testing issues, and even the fact that they can do their own monitoring all seems OK. But then I get to some of the concerning bits.
First of all, they cite patient safety as a possible trigger. Now, ONC-ACB's are already certifying systems according to safety enhanced designed requirements, and I can see where if something came up with regard to patient safety where that was an issue, it becomes something that needs to be looked at, and frankly, as a patient, I'm very happy that ONC may decide to do its own looking.
But then there's this nebulous area where Certified components interacting with non-certified components come into play. And that's where the challenge starts to show up. This starts to give ONC oversight of EHR system components that aren't involved with the certification program, under some very loose reading of the statute as far as I can tell.
While the "purpose" for which ONC was created includes all the things they cite in the regulation, HITECH did NOT give ONC authority over all those topics described in the "Purpose". Instead, it gave them a more narrow set of requirements focused (mostly) on creating a certification program, selecting standards, and coordinating federal efforts on HIT strategy and policy.
I don't see how using the purpose statements as a justification for expansion into EHR surveillance beyond the certification program comes into play, and given that loose reading ONC could also justify taking on a large number of other roles which overlap with other agencies responsibilities:
Under similar loose readings, one could suggest that:
This is a bad idea on several fronts.
If there's a patient safety issue with certified product, certainly ONC should address it. Addressing product issues like that is already covered under the QMS (quality management system) requirements of meaningful use, and a failure of a vendor to adequately provide or execute on QMS for certified product would certainly apply in those cases.
But when we start talking about interactions with non-certified product, I have at least three concerns:
While ONC is rightly concerned that there need to be ways for some federal agency to act when a patient safety issue is discovered and not being appropriately addressed, neither its ACB's, nor frankly ONC, has the necessary experience to do so, and as I read the legislation, nor do they have the necessary authorization.
Attacking patient safety as an EHR Certification problem is not the right way to handle this. Safety is built in, not bolted on. Don't try to bolt it on to the certification process as an afterthought either. Put some real thought into how to handle the safety issue, and don't confuse the two. Talk to your colleagues over at FDA, they have a few decades of experience with addressing those sorts of challenges.
I've still got a lot more reading to do, this is just my first reaction to the first half of what I've read thus far.
Keith
P.S. As a reminder, these are my own personal views, not those of my employer or anyone else.
First of all, I look at the justification for the expansion, which looks OK in part. The bits about having oversight over the testing labs looks good, as does the fact that ONC will have a more direct role in addressing testing issues, and even the fact that they can do their own monitoring all seems OK. But then I get to some of the concerning bits.
First of all, they cite patient safety as a possible trigger. Now, ONC-ACB's are already certifying systems according to safety enhanced designed requirements, and I can see where if something came up with regard to patient safety where that was an issue, it becomes something that needs to be looked at, and frankly, as a patient, I'm very happy that ONC may decide to do its own looking.
But then there's this nebulous area where Certified components interacting with non-certified components come into play. And that's where the challenge starts to show up. This starts to give ONC oversight of EHR system components that aren't involved with the certification program, under some very loose reading of the statute as far as I can tell.
While the "purpose" for which ONC was created includes all the things they cite in the regulation, HITECH did NOT give ONC authority over all those topics described in the "Purpose". Instead, it gave them a more narrow set of requirements focused (mostly) on creating a certification program, selecting standards, and coordinating federal efforts on HIT strategy and policy.
I don't see how using the purpose statements as a justification for expansion into EHR surveillance beyond the certification program comes into play, and given that loose reading ONC could also justify taking on a large number of other roles which overlap with other agencies responsibilities:
Under similar loose readings, one could suggest that:
- Improving quality could authorize ONC to take on AHRQ responsibilities.
- Reducing costs could authorize ONC to take on CMS responsibilities.
- Just as reducing errors as presently used as a justification seems like it could authorize ONC to take on some of FDA's responsibilities.
This is a bad idea on several fronts.
If there's a patient safety issue with certified product, certainly ONC should address it. Addressing product issues like that is already covered under the QMS (quality management system) requirements of meaningful use, and a failure of a vendor to adequately provide or execute on QMS for certified product would certainly apply in those cases.
But when we start talking about interactions with non-certified product, I have at least three concerns:
- Overlap with FDA requirements for those components that are classified under medical device regulations.
- Confusion about responsibilities when certified components and non-certified components are described as a single unit.
- Confusion about vendor responsibilities when the challenge may be introduced by product interactions between multiple vendors, some of which may be certified.
- Issues where the root cause could be "modification" in the field by non-vendor personnel.
While ONC is rightly concerned that there need to be ways for some federal agency to act when a patient safety issue is discovered and not being appropriately addressed, neither its ACB's, nor frankly ONC, has the necessary experience to do so, and as I read the legislation, nor do they have the necessary authorization.
Attacking patient safety as an EHR Certification problem is not the right way to handle this. Safety is built in, not bolted on. Don't try to bolt it on to the certification process as an afterthought either. Put some real thought into how to handle the safety issue, and don't confuse the two. Talk to your colleagues over at FDA, they have a few decades of experience with addressing those sorts of challenges.
I've still got a lot more reading to do, this is just my first reaction to the first half of what I've read thus far.
Keith
P.S. As a reminder, these are my own personal views, not those of my employer or anyone else.
Keith - can you be more specific? Precisely which words/statements constitute a loose reading of the statue?
ReplyDeleteJacob: See https://www.federalregister.gov/articles/2016/03/02/2016-04531/onc-health-it-certification-program-enhanced-oversight-and-accountability#p-100
Delete"In a manner consistent with" is related back to ONC Purpose as defined in HITECH, but I don't see it as an authorization to take on regulation to address everything in that paragraph.
Thus, when that statement, combined with grant of regulatory authority to address issues in non-certified components, I think the interpretations comes out as being somewhat lose. ONC clearly has authority over certification program and how it operates, but I do not see it as having been granted authority over non-certified product. I don't think ONC has explored the unintended consequences of what they seek.